{"id":4058,"date":"2025-05-23T23:03:08","date_gmt":"2025-05-23T23:03:08","guid":{"rendered":"https:\/\/mailitics.com\/index.php\/2025\/05\/23\/biotech-news-novo-gsk-crispr-prime-copd-merus-keytruda-cancer-the-readout\/"},"modified":"2025-05-23T23:03:08","modified_gmt":"2025-05-23T23:03:08","slug":"biotech-news-novo-gsk-crispr-prime-copd-merus-keytruda-cancer-the-readout","status":"publish","type":"post","link":"https:\/\/mailitics.com\/index.php\/2025\/05\/23\/biotech-news-novo-gsk-crispr-prime-copd-merus-keytruda-cancer-the-readout\/","title":{"rendered":"GSK drug\u2019s new approval sets up competition with Dupixent"},"content":{"rendered":"<p>    GSK drug\u2019s new approval sets up competition with Dupixent<br \/>\n \t<BR><br \/>\n<BR><\/BR><br \/>\n    <!-- no image --><br \/>\n \t<BR><br \/>\n<BR><\/BR><\/p>\n<div>\n<p><em>Want to stay on top of the science and politics driving biotech today?\u00a0<a href=\"https:\/\/www.statnews.com\/signup\/readout\/\">Sign up<\/a>\u00a0to get our biotech newsletter in your inbox.<\/em><\/p>\n<p>Good morning. Apologies that this newsletter is coming late to you this morning \u2014 we had some technical difficulties. But we\u2019ve still got the news for you today.GLP-1<\/p>\n<p><a href=\"https:\/\/www.statnews.com\/2025\/05\/23\/biotech-news-novo-gsk-crispr-prime-copd-merus-keytruda-cancer-the-readout\/?utm_campaign=rss\">Read the rest\u2026<\/a><\/p>\n<\/div>\n<p> \t<BR><br \/>\n <BR><\/BR><br \/>\n    Elaine Chen<br \/>\n \t<BR><br \/>\n<BR><\/BR><br \/>\n<a href=\"https:\/\/www.statnews.com\/2025\/05\/23\/biotech-news-novo-gsk-crispr-prime-copd-merus-keytruda-cancer-the-readout\/?utm_campaign=rss\">Go to statnews<\/a><br \/>\n \t<BR><br \/>\n <BR><\/BR><\/p>\n","protected":false},"excerpt":{"rendered":"<p>GSK drug\u2019s new approval sets up competition with Dupixent Want to stay on top of the science and politics driving biotech today?\u00a0Sign up\u00a0to get our biotech newsletter in your inbox. Good morning. Apologies that this newsletter is coming late to you this morning \u2014 we had some technical difficulties. But we\u2019ve still got the news [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2194,2154,58,2208,2209,2176,858,2207],"tags":[2150],"class_list":["post-4058","post","type-post","status-publish","format-standard","hentry","category-biotech","category-biotechnology","category-business","category-drug-development","category-drug-prices","category-pharma","category-research","category-the-readout","tag-statnews"],"_links":{"self":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/4058"}],"collection":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/comments?post=4058"}],"version-history":[{"count":0,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/4058\/revisions"}],"wp:attachment":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/media?parent=4058"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/categories?post=4058"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/tags?post=4058"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}